Croyez Bioscience

🌟 Illuminate Your Research with Our Special Offer! 🌟
Dive into cutting-edge science with our Reporter Gene mRNA Products!
For a limited time, BUY 2 and GET 1 FREE.
🔹 Duration: July 15th - September 15th, 2024
🔹 Who Can Participate: Everyone!

Choose any three products from our range and add a splash of color to your experiments.
🔎Reporter Gene mRNAs
https://reurl.cc/kODaLb

Contact your local distributors NOW!
🔗https://reurl.cc/OMOrgy

For specific color requests, feel free to contact our support team [email protected]. We have more colors coming soon!

The Perfect Solution: Two Sizes in One!

🔬 Attention researchers! Elevate your work with the precision, sharpness, and reliability of our RNA ladders.

🛒 Special Offer: Purchase a 50µL RNA Ladder (0.2k-6k) or High Range RNA Ladder (0.2k-12k) and receive a complementary 10µL RNA ladder with your order!

🔹Duration: July 1st - August 31st, 2024
🔹Who Can Participate: Everyone!

🔎RNA Ladders
https://reurl.cc/LW2pN9

Contact your local distributor NOW!
🔗https://reurl.cc/OMOrgy

📢 Exciting news! We've teamed up with Biomol GmbH, our new distributor, to expand our product offerings and services.
Biomol is dedicated to fulfilling the critical demand for top-notch promptly, catering to cutting-edge biotechnology research needs. Their main focus is on partnering with leading global suppliers, ensuring access to partner products in to support innovative research within optimal timelines.
Thank you for your ongoing support, and stay tuned for more updates!
Explore further🔎 https://www.croyezbio.com/

🎉 Exciting Announcement! 🎉
We're thrilled to share that two of our partners have recently obtained regulatory approval from TFDA for their groundbreaking cell therapy treatments, with a nod to our top-tier GMP grade recombinant proteins. Explore how we're propelling advancements in regenerative medicine and pushing the limits of biotechnology.

Know more now 🔎 https://lnkd.in/gaHCRYWm

🚀

🧧Just achieved our first team goal. We had the best spring party ever, filled with remarkable moments, delightful cuisine, red envelopes, and exciting games! A big shoutout to everyone who contributed their behind-the-scenes efforts over the past few months in making this event truly fun.

🌟 The Power of IL-18: Boosting NK Cells Against Cancer 🌐

IL-18 emerges as a potent force in the battle against cancer, enhancing the effectiveness of NK cells. Originating from adipocytes and macrophages, IL-18 undergoes enzymatic activation and intricate regulatory processes. Its impact on immunity is profound, influencing T-cells, natural killer cells, and modulating downstream immune responses.

Our latest article further explores IL-18's synergy with IL-2, offering potential improvements in NK cell-based cancer treatments. IL-18's recognized potential in combination therapies showcases its versatility in cancer immunotherapy and beyond.

Learn more now🔎 https://pse.is/5kl58f

🚀 Stay ahead in the game!
Considering the market insight report for exosome therapeutics, forecasting a significant market growth of approximately $140 million USD from 2023 to 2032. Our extracellular vesicle human CD9, CD63, and CD81 antibody collection stands out as an essential tool for detecting extracellular vesicles (EVs) derived from human cells. These antibodies target proteins expressed on EVs and are widely recognized markers in the analysis and isolation of these cell-derived particles.

Unlock the potential of your EV research with our high-quality antibodies, ensuring precision, reliability, and unparalleled insights.
🔎 Anti-CD9 Antibody, Anti-CD63 Antibody, Anti-CD81 Antibody
https://pse.is/5jkvb6

🟢💚✅

Ensuring the validation of your target mRNA delivery system is not only critical but also indispensable. Croyez provides tools that simplify the monitoring of transfection efficiency and assessment of expression duration.

Adapt your approach based on your preferences – opt for fluorescent mRNA, like EGFP, or luminescent options such as firefly luciferase as your reporter gene. For example, employing EGFP allows for direct observation of protein accumulation in living cells, facilitating preliminary analysis before delving into quantitative measures.

In the case of luminescence, the heightened sensitivity significantly enhances assay performance, particularly in complex biological samples or in vivo experiments.

Elevate the standard of your research by utilizing Croyez's positive controls for mRNA delivery system testing.
🔗 https://pse.is/5j3bya

Reach out to us for further information and inquiries.
✉ [email protected]

📢 We're pleased to announce that we've partnered with a new distributor, XL Biotec Co Ltd, to bring you even more amazing products and services.

XL Biotec is committed to meeting the critical need for high-quality in a timely manner for cutting-edge biotechnology research. Their primary focus is to identify and collaborate with top global suppliers, making partner's products accessible in to support groundbreaking research within an optimal timeframe.

Thank you for your continued support, and stay tuned for more updates!

Discover more now🔎 https://pse.is/56ajnw

The iCARM Inaugural Conference took place on December 12, 2023, at the Taipei Bioinnovation Park, forming a grand alliance through a strategic collaboration based on the Coopetition concept, offering comprehensive Proof of Concept services.

Croyez, along with numerous enterprise partners, collaborates to establish a more robust platform to support regenerative medicine. While Croyez, as an alliance member, continues to provide high-quality raw material solutions, other partners contribute various services, including integrated services in the regenerative medicine field, a supply chain for laboratory consumables, manufacturing of biologically specific antibodies, continuous and precise gene monitoring, cell tracking technology, digitalization interconnection in the biotech field, GTP environment customization, high-quality regenerative medicine materials and services, and non-invasive cell capture technology.

The alliance anticipates leveraging the unique expertise and services of its members to collectively overcome challenges in the development of the regenerative medicine industry.

Related News🔗 https://pse.is/5fwqy2
Our Solution for Cell Therapy🔗 https://pse.is/5fwqzt

🌟 The second day of Healthcare+ Expo Taiwan held at Taipei Nangang Exhibition Center 📅 from November 30th - December 3rd (Sun) 2023. Our manager gave a speech on the opening day to share how Croyez's raw materials can assist cell therapy more accurately.

In addition, Croyez has also become a member of iCARM, and you can also find our footprints at booth M411a. iCARM connects Taiwan's regenerative medicine-related industries and integrates resources such as scientific research, medical institutions and enterprises.

If you are interested in Croyez's service, don’t miss this wonderful chance to meet us on-site. Our professionals are waiting for you to chat at 📍N513A (4F, No. 1, Jingmao 2nd Rd, Nangang District, Taipei City)

Don’t miss the last two days on the weekend!

Visitors who are unable to come to meet us are also welcome to fill out the service form and our professionals will contact you :)
✏️ https://pse.is/5f9xul

➡️ Visit the exhibition and register at https://pse.is/5dwax4

🔬More inspiration at https://pse.is/5e6r93

#醫療科技展

Taiwan's National Health Insurance (NHI) system expanding coverage for CAR T-cell therapy to patients with acute lymphoblastic leukemia (ALL) and relapsed or refractory diffuse large B cell lymphoma (DLBCL) is a significant breakthrough.

As a company specializing in providing recombinant proteins for cell therapies, we recognize the pivotal role of advanced protein technologies in CAR T-cell treatments. Our expertise in this field positions us uniquely to contribute to the progress of such innovative therapies. The NHI's decision reflects a positive step forward, and the high cost and installment payment approach underscore the complexities of these advanced treatments.

If interested in learning more about our company's contributions to this field, please feel free to contact us.

Discover more at 🔎 https://pse.is/56ajnw

NHI to cover CAR T-cell therapy for two types of cancer from November - Focus Taiwan Taipei, Oct. 16 (CNA) From November, patients with two types of cancers will be eligible to receive CAR T-cell treatment under Taiwan's National Health Insurance (NHI) system, the National Health Insurance Administration (NHIA) said Sunday.

🎁 Don't miss out on the biggest sale of the year!
Our Black Friday discounts are just around the corner, with exceptional discounts on all products. Get ready to enjoy amazing deals!

🌟 Discounts on everything:
• GMP and RUO Recombinant Proteins
• mRNA Materials and Products
• Allergen Materials
• Other Croyez's Products

Enjoy it now! 🔎 https://pse.is/59l4gr

✨ See What's New! It's our latest product - GMP IL-18 Tag-Free Recombinant Protein!

At Croyez, we're thrilled to present our upgraded GMP grade IL-18, now available in a tag-free version:
✅ Preserving Native Protein Structure: Typically, tag-free recombinant proteins closely mimic their natural counterparts, guaranteeing that your experiments closely align with the authentic biological structure.
✅ Enhanced Compatibility: Perfect for studies that demand the highest level of protein purity, minimal interference in protein-protein interactions, and optimal compatibility with biological systems.
✅ Elevated Biological Relevance: Ideal for applications where the biological activity of IL-18 is paramount, such as in therapeutic development, structural analysis, and functional studies.
✅ The Gold Standard for GMP: With the GMP-grade quality assurance, rest assured that our IL-18 tag-free recombinant protein meets the highest industry standards, making it a top choice for your cell therapy research.
✅ Still Maintaining Great Stability: Our tag-free IL-18 is known for its exceptional stability, guaranteeing reliable and consistent results for your research.

Elevate your research and take your experiments to the next level! Know More 🔎 https://pse.is/5brl99

or Contact us today! 📩 [email protected]

Commonality of science and music 🎵

🧬🚀 The Future of mRNA: Self-amplifying mRNA's Promise and Challenges

In recent years, self-amplifying mRNA (saRNA) has emerged as a groundbreaking technology that holds immense promise in the field of molecular biology and medicine. This cutting-edge innovation has the potential to revolutionize the way we approach disease treatment and vaccine development. In this blog post, we will dive into the fascinating world of self-amplifying mRNA, exploring how it works and its exciting range of applications.

Let Croyez AI assistant - Bella read for you:
https://pse.is/5bawqt

📢 We're pleased to announce that we've partnered with a new distributor, 유어랩 YourLAB, to bring you even more amazing products and services.

YourLab is dedicated to elevating customer satisfaction through swift and precise service. As direct importers and distributors, they offer high-quality products to researchers, ensuring speedy delivery and competitive prices across various life science domains, including molecular biology, immunology, cell biology, and biotechnology.

Thank you for your continued support, and stay tuned for more updates!

Discover more now🔎 https://pse.is/56ajnw

🚀✨New Heights Achieved!
The Masters Battle mRNA Length Challenge has concluded with astounding results! We're thrilled to announce that the best result surpassed our expectations. One participant successfully synthesized a 13,000 nt target mRNA using Croyez mRNA material, despite using a DNA ladder as a comparative marker. Without a doubt, this achievement sets a new standard and inspires all of us.

Sincerely thanks to all participants for invaluable contributions and collaborative spirit. Croyez remains committed to driving innovation.

Related product🔎 http://pse.is/5a9pt2
mRNA Expert Insights🔎 http://pse.is/5a6rns

One of the common questions we often encounter is, "What would happen if the DNA template purity wasn't good enough when performing IVT synthesis?" The insights shared by our experts indicate that it's likely related to RNase A.

We've just released our new mRNA Expert Insights to Common Questions Essential FAQs Handbook!
📘💡Download it today to find answers to your most pressing questions:
http://pse.is/5a6rns

✨🔬 Explore the future of cancer treatment in the latest article, "A Different Kind Of Cancer Killer: Enhancing CAR NK Cell Therapy" by William A. Haseltine. This article sheds light on the promising prospects of CAR NK cell therapy in cancer treatment and emphasizes the importance of addressing issues related to metabolic fitness for its clinical success.

Unlike conventional CAR T therapy, CAR NK cells present a promising alternative to overcome various limitations in cancer treatment. In the realm of cancer therapy, the study uncovers a critical insight into the challenges faced by natural killer (NK) cells equipped with chimeric receptors and offers potential solutions. Natural killer cells are distinct from cytotoxic T cells and present a different approach to combating cancer. They possess the ability to target cancerous cells without the need for prior exposure to specific antigens.

A significant focus is on the role of interleukin-15 (IL-15) in CAR NK therapy. Researchers explore how IL-15 can enhance the metabolic fitness of NK cells, improving their function and effectiveness in eradicating cancer. Additionally, the article discusses the potential of double dosing with IL-15-expressing CAR NK cells as a strategy to combat the weakening of their antitumor responses over time.

Join us in the journey towards more effective & accessible cancer treatments! 💪 🌟

Croyez GMP ® IL-15 (Interleukin-15), Human
🔎http://pse.is/5a2u85

Learn more how to culture NK Cell
🔎http://pse.is/595qly

A Different Kind Of Cancer Killer: Improving CAR NK Cell Therapy One study discovers why CAR NK cells lose steam over time and suggests a way to rejuvenate their cancer-killing ability.

🧬💡📖 Few tips to make mRNA more stable.

Two significant players emerge in the world of mRNA enhancements: capping and pseudouridine substitution. Consider capping as the reinforcement, improving mRNA's adaptability and translation skill through a clever modification at its 5' end. In the meantime, pseudouridine acts as a guardian, reducing the dangers of immunological reactivity and cellular enzyme interference, ultimately improving the security and efficacy of mRNA vaccines and treatments.

Future medical treatments will be more dependable in addition to being more potent thanks to these molecular improvements.

Take active steps to strengthen your mRNA now 🔎 http://pse.is/58swup

✨ New Service✨
Speeding Up Your Research Excellence 🚀 Croyez Launches Accelerated IVT mRNA Synthesis Service for Therapeutics and Research Advancements

mRNA expands therapy potential for diseases. Focused on mRNA production enables personalized medicines, including vaccines and protein replacements.

Croyez recently launched a comprehensive solution, streamlining gene synthesis to IVT mRNA production. Our in vitro transcription expertise allows customization, delivering reliable mRNA tailored to your research goals.

Know more now🔎 https://pse.is/58pyby
-
Reach out to us for further information and inquiries.
✉️ [email protected]

When it comes to the submission deadline…

Find ideas for your research🔎https://pse.is/5725bx
credit: Hannah Hillam